Screening and application of thermophilic butyricum transcriptional regulation protein TrpR mutant
By constructing a biosensor by mutation of TrpR transcriptional regulatory protein of butyrate, the problem of rapid detection of 5,6-dihydroxyindole content in the prior art was solved, and efficient and rapid detection effect was achieved.
Patent Information
- Application Number
- CN202411314984.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-20
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-09-20
AI Technical Summary
The prior art cannot quickly and sensitively detect the content of 5,6-dihydroxyindole, and the production of bioconversion production is relatively low, limiting industrial production.
By performing specific mutations on TrpR, a transcriptional regulator protein of et al. butyrate, a biosensor bound to fluorescent reporter gene was constructed, and the concentration of 5,6-dihydroxyindole was detected using the fluorescence expression intensity reaction.
It achieves efficient and rapid detection of 5,6-dihydroxyindole content, ensures the extraction efficiency and purity of the target components, and lays the foundation for industrial production.
Smart Images

Figure CN118994334A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of genetic engineering, and in particular relates to the screening of TrpR mutants of Thermomyces butyricus transcriptional regulatory protein and application thereof. Background Art
[0002] As a natural organic compound, 5,6-dihydroxyindole shows great potential in the development of green and safe hair dyes. Traditional chemical hair dyes contain many irritating or harmful chemicals, while 5,6-dihydroxyindole, as a natural ingredient, can not only provide coloring effects comparable to traditional chemical dyes, but also reduce irritation to the scalp and hair and reduce the impact of chemicals on the environment. In addition, 5,6-dihydroxyindole also has good biocompatibility and safety, making it an ideal choice for the development of green and safe hair dye products.
[0003] Currently, the methods used to detect 5,6-dihydroxyindole content on the market mostly rely on traditional chemical analysis techniques, such as high-performance liquid chromatography (HPLC) and mass spectrometry. Although these methods are accurate, they usually require expensive equipment and professional operators, and the process is cumbersome and not suitable for rapid on-site detection.
[0004] Due to these limitations, it is particularly important to develop a new detection method that is both rapid and sensitive. Summary of the invention
[0005] In view of the deficiencies of the above-mentioned prior art, the present invention provides the screening of TrpR mutants of the transcriptional regulatory protein of Thermomyces butyricum and its application in detecting the content of 5,6-dihydroxyindole, aiming to solve the technical problems that Lactobacillus plantarum cannot be directly used to produce 5,6-dihydroxyindole, and the yield of 5,6-dihydroxyindole produced by bioconversion is low, which limits its industrial production.
[0006] The first technical solution provided by the present invention is a transcription regulatory protein mutant, which is a tyrosine mutation at position 36, a lysine mutation at position 37, an alanine mutation at position 38, and a leucine mutation at position 39 of the transcription regulatory protein TrpR parent, and the amino acid sequence of the parent is shown in SEQ ID NO: 1.
[0007] The parent is derived from Thermomyces butyricum, and the nucleotide sequence encoding the parent gene is shown in SEQ ID NO:2.
[0008] In certain embodiments, the mutant is a mutant in which the tyrosine Y at position 36 of the parent is mutated to lysine K, the lysine K at position 37 is mutated to phenylalanine F, the alanine A at position 38 is mutated to glycine G, and the leucine L at position 39 is mutated to proline P. The amino acid sequence of the mutant is shown in SEQ ID NO: 3.
[0009] In certain embodiments, the nucleotide sequence encoding the mutant gene is shown in SEQ ID NO:4.
[0010] The second technical solution provided by the present invention is a gene encoding the mutant described in the first technical solution.
[0011] In certain embodiments, the nucleotide sequence encoding the mutant gene is shown in SEQ ID NO:4.
[0012] The third technical solution provided by the present invention is an expression vector carrying the gene described in the second technical solution.
[0013] In certain embodiments, the expression vector comprises a pBAD / HisA vector.
[0014] The fourth technical solution provided by the present invention is a genetically engineered bacterium that expresses the mutant described in the first technical solution, or contains the gene described in the second technical solution, or is transformed with the expression vector described in the third technical solution.
[0015] In certain embodiments, the genetically engineered bacteria uses Escherichia coli as a starting strain.
[0016] Preferably, the starting strain comprises E. coli MC1061.
[0017] The fifth technical solution provided by the present invention is an indicator plasmid, which is an expression vector containing a gene encoding the mutant described in the first technical solution and a fluorescent reporter gene, wherein the fluorescent reporter gene is located downstream of the gene encoding the mutant, and the mutant binds to 5,6-dihydroxyindole to release the transcriptional inhibition of the fluorescent reporter gene by the mutant, and the indicator plasmid can be used to sense the concentration of 5,6-dihydroxyindole to regulate the transcription intensity of the fluorescent reporter gene.
[0018] The sixth technical solution provided by the present invention is an indicator strain, which is an Escherichia coli containing the indicator plasmid described in the fifth technical solution, and can reflect the concentration of 5,6-dihydroxyindole in the environment through the intensity of fluorescence expression.
[0019] The seventh technical solution provided by the present invention is a method for detecting 5,6-dihydroxyindole, which utilizes the fluorescence expression intensity of the indicator strain described in the sixth technical solution to characterize the content level of 5,6-dihydroxyindole in the sample to be detected.
[0020] The eighth technical solution provided by the present invention is the use of the mutant described in the first technical solution, or the indicator plasmid described in the fifth technical solution, or the indicator strain described in the sixth technical solution, or the method described in the seventh technical solution in the construction of a biosensor that responds to 5,6-dihydroxyindole.
[0021] The technical effects of the present invention are as follows:
[0022] Through the screening of TrpR mutants, the transcriptional regulatory protein TrpR of Thermomyces butyricum was modified to enhance its specificity in response to 5,6-dihydroxyindole. A special biosensor was constructed in combination with a fluorescent reporter gene to effectively detect the content of 5,6-dihydroxyindole, ensuring the efficiency and purity of the extraction of the target component, laying a solid foundation for subsequent applications and research. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is the map of the pTrpR expression plasmid.
[0024] Figure 2 Comparison of the performance of wild-type TrpR and mutant Trp-M.
[0025] Figure 3 Induction of specificity for a whole-cell biosensor that specifically responds to 5,6-dihydroxyindole. DETAILED DESCRIPTION
[0026] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explaining the present invention and are not used to limit the present invention.
[0027] The raw materials used in the examples are:
[0028] 1. pBAD / HisA and DsRed vectors were from Invitrogen.
[0029] 2. Escherichia coli MC1061 was purchased from Quanshijin Company.
[0030] 3. LB medium formula: tryptone 10g / L, yeast extract 5g / L, sodium chloride 10g / L, adjust pH = 7.4.
[0031] Example 1 Obtaining TrpR mutants
[0032] 1. Construction of wild-type recombinant plasmid
[0033] PCR amplification was performed using pBAD / HisA vector as a template and 5'-CGGTACCCGGGGATCCACTA-3' (forward primer, SEQ ID NO: 5) and 5'-CTCGAGCTCGGATCCCCATC-3' (reverse primer, SEQ ID NO: 6) as primers. The genome of Thermomyces butyricus (GenBank: CP000493.1) was extracted as a template, and the trpR gene (SEQ ID NO: 2) was amplified using primers 5'-GATGGGGATCCGAGCTCGAGATGCCCTCCGTTAACGACTG-3' (forward primer, SEQ ID NO: 7) and 5'-TAGCTGTACTCTTCGAGCTCTTACTTGAGTCCAAGCTTTT-3' (reverse primer, SEQ ID NO: 8). The DsRed plasmid (GenBank: MZ332518.1) was used as a template, and the 5'-CGGCGCTCAGTTGGAGATCTCTACAGGAACAGGTGGTGGC-3' (forward primer, SEQ ID NO: 9) and 5'-TAGTGGATCCCCGGGTACCGATGGCCTCCTCCGAGGACGT-3' (reverse primer, SEQ ID NO: 10) were used to amplify the trpR gene (SEQ ID NO: 2). NO: 10) were used as primers to amplify the rfp gene (GenBank: QWX95862.1). PCR system: 0.2 μM of each primer, 0.2 mM of dNTPs, 10 ng of template, 5 μL of 2×Buffer, 0.5 μL of Hieff, and deionized water to make up the volume to 100 μL. PCR reaction conditions were: 94°C for 20 s, 94°C for 30 s, 55°C for 30 s, 72°C for 2 min, 4°C for 5 min, and 30 cycles of the above 2-5 steps. The obtained PCR products were connected using the Gibson Assembly Kit (Anhui General Biology), and the connected products were transferred to obtain recombinant bacteria. The plasmid of the recombinant bacteria was extracted to obtain the recombinant plasmid pBAD / HisA-TrpR-RFP. The plasmid map is shown in Figure 1 .
[0034] 2. Construction of trpR error-prone mutant library
[0035] Error-prone PCR was performed on the trpR gene (SEQ ID NO: 4) using primers 5'-ATGCCCTCCGTTAACGACTG-3' (forward primer, SEQ ID NO: 11) and 5'-TTACTTGAGTCCAAGCTTTT-3' (reverase primer, SEQ ID NO: 12). The error-prone PCR system was 0.2 mM dATP, 1 mM dCTP, 1 mM dTTP, 0.025 mM MnCl2, 10×PCRBuffer 10 μL, rTaq 0.5 μL, and the volume was made up to 100 μL with deionized water, and then evenly distributed into 10 PCR tubes. Error-prone PCR reaction conditions were: 94°C 2 min, 94°C 30 s, 50°C 30 s, 72°C 1 min, 4°C 5 min, and the above program was repeated for 30 cycles. The obtained PCR product was subjected to MEGAWHOPE PCR using pBAD / HisA-TtgR-RFP as a template (p TrpR expression plasmid, SEQ ID NO: 13). The reaction system was: 0.2 μg of the PCR product obtained by the above error-prone PCR, 1 mM dNTPs, 30 ng of template pTrpR, 5 μL of 10×Pyrobest Buffer, 0.3 μL of Pyrobest, and deionized water to make up the volume to 100 μL. The PCR reaction conditions were: 94°C for 2 min, 94°C for 30 s, 50°C for 30 s, 72°C for 3 min, 4°C for 5 min, and 30 cycles of the above 2-5 steps. The obtained PCR product was digested with DpnI (20 U) at 37°C for 2 h, and DpnI was inactivated at 80°C for 20 min. The trpR error-prone mutant library (mutant plasmid mixture) was obtained.
[0036] 3. Mutant Screening
[0037] The error-prone mutant library was screened using a flow cytometer. The specific operation was as follows: the plasmid of the TrpR mutant library was electroporated into MC1061 competent cells (about 10 7 cells). After 45 minutes of shaking at 37°C, the resuscitation solution was added to 50 mL of LB medium containing Amp (ampicillin resistance), and 1 mM 5,6-dihydroxyindole was added, and cultured at 37°C for 12 hours. Take 1 mL of cell suspension, centrifuge at 3,000 × g for 10 minutes, discard the supernatant and resuspend in 1 mL of PBS buffer. Take 200 μL of the suspension, mix with 1.8 mL of PBS, and add to a 5 mL round-bottom test tube. Use flow cytometry for sorting (excitation wavelength 561 nm, emission wavelength 610 nm) to select cells with higher fluorescence intensity. The sorted cells were cultured in 3 mL of LB medium for 6 hours, and the final OD 600=0.2, and then transferred to 3 mL LB medium containing 1 mM 5,6-dihydroxyindole for the second round of screening. After eight rounds of screening, 10,000 cells were collected in the last round of screening, and 300 μL of the cell suspension was spread on Amp R From the plates, single colonies were picked and replicated in tubes containing 0 mM, 0.01 mM, 0.1 mM, 1 mM, and 10 mM 5,6-dihydroxyindole.
[0038] A mutant TrpR-M (SEQ ID NO: 3) of the transcriptional regulatory protein gene trpR that can specifically respond to 5,6-dihydroxyindole induction was obtained. Sequencing showed that, relative to TrpR, the 36th amino acid of the mutant was mutated from tyrosine (Tyr) to lysine (Lys), the 37th amino acid was mutated from lysine (Lys) to phenylalanine (Phe), the 38th amino acid was mutated from alanine (Ala) to glycine (Gly), and the 39th amino acid was mutated from leucine (Leu) to proline (Pro).
[0039] The performance of wild-type TrpR and mutant Trp-M was compared using tryptophan, a natural inducer of TrpR protein, and 5,6-dihydroxyindole, a target inducer. Figure 2 shown.
[0040] Example 2 Construction of a biosensor responsive to rare 5,6-dihydroxyindole
[0041] The pTrpR-M plasmid containing the TrpR-M coding gene (SEQ ID NO: 3) was transferred into the Escherichia coli MC1061 strain to obtain the recombinant strain MC1061-TrpRM, that is, a whole-cell biosensor that can specifically respond to 5,6-dihydroxyindole induction was obtained. The induction specificity was detected by a multifunctional microplate reader: a single clone was selected and added to 3 mL LB medium containing 100 μg / mL Amp, and cultured overnight in a shaking incubator at 37°C as a seed solution. The next day, the inoculation was performed at a 1% inoculation amount (final OD 600 About 0.02), and 1mM 5,6-dihydroxyindole was added at the same time. After culturing at 37°C for 12 hours, 200μL of cell suspension was taken and the OD was measured using an enzyme marker 600 And RFP fluorescence intensity (excitation wavelength 556nm, emission wavelength 586nm). Figure 3 As shown, it is shown that the biosensor can specifically respond to the induction of 5,6-dihydroxyindole, but not to the induction of analogs such as tyrosine, dopa, and dopamine.
[0042] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A transcriptional regulatory protein mutant, characterized in that: The mutant is a tyrosine mutation at position 36, a lysine mutation at position 37, an alanine mutation at position 38, and a leucine mutation at position 39 of a transcriptional regulatory protein TrpR parent, and the amino acid sequence of the parent is shown in SEQ ID NO:
1.
2. The mutant according to claim 1, characterized in that The mutant is a mutant in which the tyrosine Y at position 36 of the parent is mutated to lysine K, the lysine K at position 37 is mutated to phenylalanine F, the alanine A at position 38 is mutated to glycine G, and the leucine L at position 39 is mutated to proline P.
3. A gene encoding the mutant according to claim 1 or 2.
4. An expression vector carrying the gene according to claim 3.
5. A genetically engineered bacterium expressing the mutant according to claim 1 or 2, or containing the gene according to claim 3, or transformed with the expression vector according to claim 4.
6. The genetically engineered bacterium according to claim 5, characterized in that: The genetically engineered bacteria uses Escherichia coli as a starting strain.
7. An indicator plasmid, characterized in that The indicator plasmid is an expression vector containing a gene encoding the mutant according to claim 1 or 2 and a fluorescent reporter gene, wherein the fluorescent reporter gene is located downstream of the gene encoding the mutant, and the mutant binds to 5,6-dihydroxyindole to release the transcriptional inhibition of the fluorescent reporter gene by the mutant, and the indicator plasmid can be used to sense the concentration of 5,6-dihydroxyindole to regulate the transcription intensity of the fluorescent reporter gene.
8. An indicator strain, characterized in that The indicator strain is an Escherichia coli containing the indicator plasmid according to claim 7, and can reflect the concentration of 5,6-dihydroxyindole in the environment through the intensity of fluorescence expression.
9. A method for detecting 5,6-dihydroxyindole, characterized in that: The method is to use the fluorescence expression intensity of the indicator strain described in claim 8 to characterize the content level of 5,6-dihydroxyindole in the sample to be detected.
10. Use of the mutant according to claim 1 or 2, or the indicator plasmid according to claim 7, or the indicator strain according to claim 8, or the method according to claim 9 in the construction of a biosensor responsive to 5,6-dihydroxyindole.
Citation Information
Patent Citations
Recombinant bacterium for preparing melanin through fermentation by taking tyrosine as substrate and application of recombinant bacterium
CN118325801A
